DroobiSmit

DroobiSmit specializes in providing personalized chronic disease management solutions, focusing on diabetes remission, weight management, and metabolic health. The company operates primarily in the GCC and South Asia, serving over 40,000 end users. DroobiSmit partners with healthcare, pharmaceutical, and government insurance leaders to deliver evidence-based programs that aim to reduce diabetes levels and associated care costs. The business model revolves around leveraging cutting-edge AI and industry expertise to create impactful health transformations. Revenue is generated through partnerships and collaborations with both public and private sectors, offering best-in-class clinical impact. The company is led by experienced executives who have driven large-scale technology transformations across various institutions over the past two decades. Keywords: diabetes, weight management, metabolic health, GCC, South Asia, AI, healthcare, partnerships, chronic disease, clinical impact.